Pharmacist intervention may help identify potential opioid abuse early

Concurrent drug utilization review catches opioid abuse upstream

July 21, 2016

Concurrent drug utilization review (DUR) may cast wider net for catching potential opioid abuse upstream

A pharmacist intervention (DUR) may impact potential opioid misuse and abuse. This study identified at-risk members at the time they submit their opioid prescription. A soft edit (point of service) intervention delayed or altered claims for 42% of the members in the study.

Impact of a Concurrent Drug Utilization Review Edit Designed to Curb Opioid Misuse (Spring 2016)

Related news


March 30, 2023

Drug oversupply, or stockpiling, due to overlapping drug refills can cause unnecessary drug costs

If you have a chronic condition, your pharmacy may notify you advance of…


March 28, 2023

Biosimilars are at the door, Part 3

News about biosimilars is everywhere. Sometimes you just need the basics. This four-part…


March 27, 2023

Specialty Drug Pipeline Update: March 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…